Company Overview of Cytonics Corporation
Cytonics Corporation is a research and development company developing molecular diagnostic and therapeutic products for chronic orthopaedic and musculoskeletal diseases. It offers biotechnology based treatments for osteoarthritis and back and joint pain. The company’s products include autologous platelet-integrated concentrate (APIC) and autologous cell-free alpha-2-macroglobulin (a2M) concentrates. Cytonics Corporation was founded in 2006 and is headquartered in Jupiter, Florida.
555 Heritage Drive
Jupiter, FL 33458
Founded in 2006
Key Executives for Cytonics Corporation
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cytonics Corporation, please visit www.cytonics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.